Antisclerotic therapy for chronic prostatitis by rectal electrophoresis

Introduction. Chronic prostatitis is a widespread disease in men of different age groups. Chronic prostatitis remains one of the most difficult problems in modern urological practice, which also has enormous social significance for a number of reasons: a negative impact on the quality of life of patients, a frequent association with male infertility, high treatment costs and low effectiveness. The most significant pathogenetic factors of the disease are circulatory disorders and chronic inflammation, leading to the development of fibrosis of the organ and disruption of its function. In this regard, a promising direction for improving the results of treatment of patients with chronic prostatitis is the inclusion in complex therapy of measures aimed at preventing the development of fibrosis. 34 patients of group 1 received complex drug therapy in combination with rectal electrophoresis of the drug Longidaza 3000 IU. Patients of group 2 received only drug therapy. The duration of treatment was 1 month. It has been established that the use of Longidase 3000 IU by rectal electrophoresis in patients with chronic prostatitis restores microcirculation in the prostate gland, relieves dysuria, pain and achieves lasting symptomatic improvement for a longer period. The aim - to evaluate the effectiveness of Longidase* administration through rectal electrophoresis in combination with the therapeutic effects of electric currents in the complex treatment of chronic prostatitis.